Structurally, the primary cilium is an elegant piece of cellular engineering. It is anchored by the mother centriole-derived basal body, which during the G0/G1 phase or differentiation docks at the plasma membrane and nucleates a 9+0 microtubule axoneme enclosed in a specialized ciliary membrane. Assembly, maintenance and signaling competence depend on intraflagellar transport, in which IFT-A and IFT-B complexes ride along the axoneme with kinesin-2 and cytoplasmic dynein-2 motors, ferrying cargo in both directions. At the ciliary base, transition fibers and the transition zone act as a selective gate, restricting which receptors, ion channels, transporters and signaling molecules can enter. This selective compartmentalization is what allows the cilium to function as a spatially restricted signaling hub rather than a simple membrane protrusion, concentrating machinery for Hedgehog, G protein-coupled receptor, calcium, receptor tyrosine kinase, TGF-beta and Wnt pathways within a nanometer-scale compartment.

The review’s central conceptual move is to treat the cilium as plastic rather than static. Environmental cues continuously remodel its assembly, length, composition and signaling output. Glucose deprivation, for example, promotes cilium formation in cultured cells mainly through inactivation of the nutrient sensor mTORC1 rather than through autophagy, and intriguingly it increases the proportion of ciliated cells while shortening the cilia themselves, showing that assembly and morphology are regulated separately. Glutamine deprivation tells an even more dramatic story in pancreatic ductal adenocarcinoma: the stress induces a protein called melanophilin, which accumulates at the basal body and drives ciliary regrowth, and the reassembled cilia amplify phospholipase C-gamma1 signaling in a feedforward circuit that promotes metastasis. Endogenous metabolic programs matter too. Local phosphoinositide remodeling at the centrosome recruits tau tubulin kinase 2, triggering removal of CP110, a cap that blocks axoneme extension, while cholesterol accessibility within the ciliary membrane modulates Smoothened activity in the Hedgehog pathway. Conversely, activation of SREBP1-driven lipogenesis and fatty acid synthesis suppresses ciliogenesis, in part by distorting vesicular trafficking.

Mechanical forces provide a second major class of inputs. In renal epithelial cells, urinary flow bends the apical cilium and activates calcium signaling through the polycystin-1 and polycystin-2 complex, proteins whose disruption causes polycystic kidney disease. Cilia-mediated flow sensing also regulates shear-dependent apical endocytosis in proximal tubules, linking mechanotransduction to reabsorptive function. In vascular endothelium the picture is context-dependent: cilia are retained under static or disturbed-flow conditions, whereas sustained laminar shear promotes ciliary shortening or disassembly, altering the cell’s capacity for cilia-dependent nitric oxide production. In bone, cilia deflect under dynamic fluid flow and are required for osteogenic responses and flow-induced calcium deposition in osteoblasts; in cartilage, they mediate compression-induced ATP release that regulates the extracellular matrix. Even substrate stiffness matters, since rigid matrices can suppress ciliogenesis through actomyosin tension-driven nuclear deformation and keratin-associated protein upregulation.

Oxygen tension adds a third layer of regulation. The von Hippel-Lindau protein, an E3 ubiquitin ligase that degrades HIF-alpha, localizes to the cilium and basal body, where it supports microtubule stability and cilium maintenance; loss of pVHL impairs ciliogenesis in renal-derived cells, and restoring it rescues cilium formation. Under hypoxia, HIF-2alpha can interact with the transport protein IFT88 to promote ciliogenesis and influence MEK/ERK signaling. The authors are careful to note that cilia are not universal hypoxia sensors but rather context-dependent platforms connecting oxygen-responsive signaling to localized ciliary regulation. Intracellular microRNAs form a distinct regulatory class: miR-129-3p promotes ciliogenesis by targeting CP110 and modulating actin dynamics, miR-669a-5p promotes ciliary elongation, and miR-182 and miR-183 are essential for maintaining the cone photoreceptor outer segments, which are highly specialized primary cilia required for vision.

Nowhere is the metabolic role of cilia more vivid than in the pancreatic islet. Beta-cell cilia compartmentalize receptors that regulate hormone secretion: insulin stimulation recruits insulin receptor isoform A to the cilium, and disrupting ciliary integrity attenuates downstream PI3K/Akt signaling. In Bbs4-deficient mice, ciliary dysfunction delays glucose clearance and impairs insulin secretion. Cilia-localized GPCRs add further control: free fatty acid receptor 4 and prostaglandin E2 receptor 4 enhance glucose-stimulated insulin secretion through cAMP-dependent pathways, while somatostatin receptor 3, activated by delta-cell somatostatin, lowers ciliary cAMP and triggers cilia-restricted calcium signaling that drives GLI2 nuclear translocation, tying GPCR signaling to the Hedgehog axis that maintains beta-cell identity. Recent work even identified endogenous GLP-1 receptors on beta-cell cilia, with loss of cilia blunting liraglutide-induced cAMP, calcium and insulin secretion. Endothelial cilia support the islet too, facilitating VEGFR2 internalization and downstream ERK and Akt signaling needed for vascularization and glucose delivery.

Lipid metabolism reveals the cilium’s capacity to integrate opposing signals. Cilium-dependent Hedgehog signaling suppresses the adipogenic transcriptional program, inhibiting fat cell differentiation, while lipid-raft organization at the ciliary base supports Akt-dependent adipogenesis and omega-3 fatty acid activation of ciliary FFAR4 initiates it. In muscle and brown fat, cilium-dependent Smoothened-calcium signaling activates AMPK, promoting glucose uptake and Warburg-like reprogramming. In renal epithelial cells, cilia couple extracellular cues to LKB1-AMPK signaling and mTORC1 suppression, and they sense fluid flow to promote lipophagy, mobilizing fatty acids from lipid droplets for mitochondrial beta-oxidation and ATP production. Prolonged shear stress promotes cilium-dependent mitochondrial biogenesis, increasing mitochondrial mass, DNA content, oxidative phosphorylation and ATP output through AMPK-PGC1alpha and TFEB-dependent programs, while decreased IFT88 expression with ciliary shortening is associated with impaired mitochondrial function in cisplatin-induced tubular injury.

Disease connections run deep. In the vasculature, endothelial cilia are enriched at arterial branch points where atherosclerosis preferentially develops, and loss of endothelial cilia promotes inflammatory activation and accelerates plaque progression; lipid droplet accumulation in endothelial cells sequesters palmitic acid, suppresses S-palmitoylation of ciliary proteins and impairs ciliogenesis. In reproduction, endometrial stromal cilia mediate Hedgehog-dependent epithelial-stromal communication during decidualization, and in endometriosis the cilia are shorter and decidualization responses reduced, with TGF-beta1 suppressing ciliogenesis by downregulating KIF3B. Trophoblast cilia are shortened in preeclamptic placentas, where inflammatory cytokines impair Hedgehog signaling and motility, and deleterious variants in the dynein-2 heavy chain gene DYNC2H1 have been identified in euploid recurrent pregnancy loss. In obesity, the melanocortin 4 receptor signals from hypothal neuronal cilia to suppress appetite, and MC4R-bearing cilia shorten with aging and overnutrition, reducing melanocortin sensitivity, energy expenditure and thermogenesis. Human type 2 diabetic islets show shortened beta-cell cilia and reduced beta-cell to delta-cell contacts, while classical ciliopathies such as Bardet-Biedl syndrome combine obesity with BBSome-dependent defects in mitochondrial dynamics.

Cancer adds a final, paradoxical dimension. Many tumors lose primary cilia as cells re-enter the cell cycle, yet under genotoxic or nutrient stress some cancer cells reassemble or elongate them as an adaptive survival strategy. Cisplatin-resistant pancreatic cancer cells regrow cilia through DNA damage signaling, and disrupting ciliogenesis resensitizes them; in glioblastoma, blocking ciliogenesis increases sensitivity to temozolomide and radiation. In neurodegeneration, LRRK2 mutations in Parkinson’s disease block ciliogenesis and cilia-dependent Sonic hedgehog signaling, while loss of cilia impairs clearance of damaged mitochondria in dopaminergic neurons; in Alzheimer’s models, neuronal cilia near amyloid plaques are shortened. The authors emphasize that ciliary remodeling is neither uniformly protective nor pathogenic, and that defining the cellular and environmental contexts in which it helps or harms will be essential. With live ciliary signaling reporters, tissue-specific manipulation models and spatial multi-omics now emerging, the field stands poised to move from describing these organelles to decoding, and perhaps therapeutically rewiring, the sensory-metabolic conversations they conduct.

Subject of Research: The role of primary cilia as sensory organelles and metabolic signaling hubs in physiology and disease

Article Title: Primary cilium as a sensory organelle and metabolic hub in health and diseases

Article References: Hou, H.-T., Chao, Y.-Y., Li, J.-N., Peng, I.-C., Lin, T.-C., Chiu, W.-T., Wang, C.-Y., & Tsai, S.-J. (2026). Primary cilium as a sensory organelle and metabolic hub in health and diseases. Journal of Biomedical Science, 33(1), Article 92. https://doi.org/10.1186/s12929-026-01291-6

Image Credits: AI Generated

DOI: 10.1186/s12929-026-01291-6

Keywords: primary cilium, ciliogenesis, metabolism, Hedgehog signaling, mTORC1, mechanotransduction, mitochondria, diabetes, obesity, ciliopathies, cancer, neurodegeneration

The appeal of sweat as a diagnostic fluid has grown steadily over the past decade. Sweat contains glucose at concentrations that correlate with blood glucose, and it can be harvested passively through a wearable patch during exercise or induced perspiration. The difficulty lies in sensitivity. Glucose levels in sweat are far lower than in blood, so any sensor intended for this matrix must detect minute quantities of the sugar against a background of salts, lactate, urea and other interfering compounds. Conventional enzymatic sensors, which use glucose oxidase to catalyze the reaction, suffer from well-known weaknesses: enzymes degrade with heat, humidity and time, losing activity within days and making long-term wearable use impractical.

Non-enzymatic sensing sidesteps this fragility by letting an inorganic catalyst do the electrochemical work directly. Cobalt oxide, specifically the spinel phase Co3O4, has emerged as a strong candidate because its cobalt ions readily shuttle between oxidation states, mediating the oxidation of glucose at the electrode surface. The catch is that bare cobalt oxide is a relatively poor electrical conductor, which limits how efficiently the electrons generated by glucose oxidation can be collected. This is precisely where the carbon nanotubes enter the picture. Multi-walled carbon nanotubes form a highly conductive, three-dimensional scaffold with enormous surface area, and when cobalt oxide nanoparticles are dispersed uniformly across this network, the two materials complement each other: the oxide supplies catalytic sites while the nanotubes provide an electron highway.

The synthesis reported by the Chennai team is deliberately simple. A hydrothermal route, in which precursor materials react in water inside a sealed vessel at elevated temperature and pressure, was used to grow the nanocomposite. Hydrothermal methods are attractive because they produce crystalline nanoparticles at relatively low cost and without exotic reagents, and the resulting particles can be tuned in size and distribution through reaction conditions. The researchers then modified a graphite electrode with the nanocomposite, creating a working sensor surface. Graphite is inexpensive, widely available and mechanically robust, which matters for any device intended to be mass-produced as a disposable or wearable component.

Characterization formed a substantial part of the study, and the authors deployed an unusually complete analytical arsenal. X-ray diffraction confirmed the crystalline structure of the cobalt oxide spinel phase, while Fourier-transform infrared spectroscopy verified the chemical bonds and functional groups present in the composite. Field-emission scanning electron microscopy revealed the morphology of the material, showing cobalt oxide nanoparticles distributed across the nanotube network, and energy-dispersive spectroscopy confirmed the elemental composition. Brunauer-Emmett-Teller measurements quantified the surface area, a critical parameter for sensing because more accessible surface means more catalytic sites in contact with the analyte. Finally, X-ray photoelectron spectroscopy probed the surface chemistry and oxidation states of the cobalt, confirming that the active species needed for glucose electrocatalysis were present at the interface where sensing actually occurs.

Electrochemical testing was carried out in 0.1 molar phosphate buffer solution at pH 7.4, a standard electrolyte that mimics physiological neutrality. The team used a battery of electroanalytical techniques, each probing a different aspect of sensor behavior. Cyclic voltammetry mapped the redox activity of the electrode as the potential was swept back and forth. Differential pulse voltammetry and linear sweep voltammetry provided higher-resolution measurements of the glucose oxidation signal. Square-wave voltammetry added another sensitive detection mode, while electrochemical impedance spectroscopy measured how readily electrons moved across the electrode-electrolyte interface, a direct indicator of charge-transfer efficiency. Chronoamperometry, in which the current is monitored at a fixed potential over time, served as the workhorse for quantitative detection, since the current step produced when glucose is added scales with its concentration.

The performance figures are striking. The sensor achieved a sensitivity of 18.47 milliamperes per millimolar per square centimeter, a high value for a non-enzymatic system, with a detection limit of 0.1 millimolar. That detection limit is relevant to the glucose concentrations expected in sweat, which typically sit well below blood levels. Equally important for real-world deployment, the electrode demonstrated strong stability, repeatability and reproducibility. After thirty days of storage, the sensor retained more than 96 percent of its original response, a figure that speaks directly to the durability problem that plagues enzymatic alternatives. Reproducibility across multiple electrodes suggests the hydrothermal synthesis is controllable enough to yield consistent devices, a prerequisite for any commercial translation.

Perhaps the most consequential test came when the researchers moved from buffer solution to artificial sweat, a synthetic formulation designed to reproduce the salt content and pH of human perspiration. Real sweat is a hostile medium for electrochemistry: chloride ions, lactic acid, urea and ascorbic acid can all generate signals that masquerade as glucose or poison the catalyst. The MWCNT/Co3O4 electrode recovered 94 percent of the expected glucose signal in this matrix, demonstrating that the composite can function under conditions that approximate the physiological environment a wearable patch would actually encounter. While artificial sweat is not identical to the genuine article, and human trials remain a necessary next step, the recovery result provides meaningful evidence that the sensing chemistry survives outside the pristine laboratory beaker.

The broader context makes the result timely. Diabetes affects hundreds of millions of people worldwide, and the burden of daily finger-stick testing drives much of the noncompliance that leads to poor outcomes. Continuous glucose monitors based on subcutaneous sensors have transformed care for many patients, but they remain invasive, expensive and require regular replacement. A truly noninvasive alternative that reads glucose from sweat could lower the barrier to frequent monitoring dramatically, particularly in resource-limited settings. Non-enzymatic electrodes are especially well suited to this vision because they tolerate temperature swings, long storage and repeated use, all of which are unavoidable in a consumer wearable. The literature on cobalt oxide and carbon nanotube composites for glucose sensing is already substantial, and the present work builds on that foundation while pushing sensitivity and stability figures forward with an unusually accessible fabrication route.

Challenges remain before a sweat-based patch built on this chemistry reaches the clinic or the drugstore. Sweat glucose correlates with blood glucose but the relationship is dynamic and influenced by sweating rate, skin conditions and individual physiology, so calibration strategies and on-body validation will be essential. The researchers tested their electrode on graphite in artificial sweat rather than in a fully integrated flexible device on human subjects, and scaling from a laboratory electrode to a manufacturable, skin-conformal sensor involves additional engineering in fluid handling, electronics and data interpretation. Nevertheless, the combination of a low-cost hydrothermal synthesis, an inexpensive graphite substrate, enzyme-free operation, high sensitivity and thirty-day stability makes the MWCNT/Co3O4 nanocomposite a credible candidate platform for the next generation of noninvasive glucose monitors. As the field of wearable diagnostics accelerates, studies like this one show how careful materials engineering at the nanoscale can translate into practical devices that patients may one day simply wear, sweat into, and read.

Subject of Research: Non-enzymatic electrochemical glucose sensing using an MWCNT/Co3O4 nanocomposite for sweat-based monitoring

Article Title: Facile hydrothermal synthesis of MWCNT/Co3O4 nanocomposite for sweat-based non-enzymatic glucose sensing in artificial sweat

Article References: Perumal, K., & B. S., S. (2026). Facile hydrothermal synthesis of MWCNT/Co3O4 nanocomposite for sweat-based non-enzymatic glucose sensing in artificial sweat. Journal of Materials Science. https://doi.org/10.1007/s10853-026-13873-8

Image Credits: AI Generated

DOI: 10.1007/s10853-026-13873-8

Keywords: glucose sensing, non-enzymatic sensor, MWCNT, cobalt oxide, Co3O4, nanocomposite, hydrothermal synthesis, sweat, wearable biosensor, electrochemistry, noninvasive monitoring, diabetes

The award carries substantial weight in both funding and prestige. It provides $3.8 million over five years under grant number DP2DK152025-01, resources that will support the continued development of Lal’s laboratory and its ambitious agenda. Established in 2007, the NIH Director’s New Innovator Award is part of the agency’s High-Risk, High-Reward Research program, and it is deliberately structured differently from conventional grants. Unlike most traditional funding opportunities, it does not require preliminary data or a detailed experimental plan. That design gives investigators an unusual degree of freedom to pursue unconventional ideas, the kind of projects that might struggle to survive the standard peer-review gauntlet but that could, if successful, open entirely new fields of inquiry.

What makes the Arctic ground squirrel such a compelling subject is a suite of physiological feats that appear to defy the rules of mammalian biology. To prepare for hibernation, the animals gain substantial weight and become less responsive to insulin, a hormonal state that in humans would be a hallmark of progressing toward type 2 diabetes. Yet when they emerge from their torpid state, they reverse those changes without ever developing the disease. The squirrels also withstand the slowest body and brain temperatures ever recorded for any mammal, dropping into a chilled state that would cause devastating damage in most species. Understanding how they accomplish these reversals, Lal argues, could reveal evolutionary solutions to some of medicine’s most stubborn problems.

The implications extend across several major categories of chronic illness. Lal’s research program is aimed at uncovering novel therapeutic strategies for diabetes, muscle wasting disorders, and ischemic injuries, conditions that collectively affect millions of patients worldwide. Ischemic injury, in which tissue is damaged by restricted blood flow and the oxygen deprivation that follows, shares mechanistic ground with the metabolic stresses hibernating animals endure. Muscle wasting, or atrophy, is a central feature of aging, prolonged immobility, cancer, and critical illness, and it remains poorly served by existing treatments. If hibernators have evolved molecular safeguards that protect their muscles and metabolic organs through months of dormancy, decoding those safeguards could point drug developers toward targets that no one has thought to pursue.

A distinctive feature of Lal’s approach is methodological. His team is developing what are known as NAMs, or New Approach Methodologies, alongside genetic tools to investigate how the squirrels’ protective abilities operate at every scale, from individual cells to the whole animal. New Approach Methodologies is an umbrella term for innovative testing strategies, often built on cell cultures, organoids, computational models, and other alternatives to traditional approaches, that are increasingly valued in biomedical research for their ability to capture complex biology in controlled, tractable systems. Pairing these tools with genetic techniques allows the lab to probe mechanisms directly rather than merely observing correlations, an essential step if findings in squirrels are ever to be translated into therapies for people.

Equally distinctive is the conceptual framing. Rather than studying only what goes wrong in disease, as much of biomedical research necessarily does, Lal’s group is asking fundamental questions about what goes right in an animal that has already solved the problem. This inversion of the standard disease model reflects a growing appreciation in physiology that nature has run countless evolutionary experiments, and that some species hold working answers to questions medicine is still formulating. Hibernation biology has attracted renewed attention in recent years precisely because the animals that hibernate appear to sidestep conditions, from insulin resistance to muscle disuse atrophy to reperfusion injury, that plague human patients.

The Arctic ground squirrel is a particularly striking example of this phenomenon. Its hibernation cycle involves dramatic swings in body mass, metabolism, and hormonal signaling, all orchestrated and then reversed with apparent ease. In humans, sustained insulin resistance typically progresses toward diabetes, and the metabolic consequences of obesity are among the most intensively studied problems in modern medicine. The squirrel’s ability to pack on weight, suppress insulin sensitivity, and then recover full metabolic health without intervention suggests the existence of endogenous protective mechanisms. Identifying the molecular switches behind that recovery is precisely the kind of fundamental question the New Innovator Award is designed to enable.

The award also marks a significant milestone for the Monell Chemical Senses Center itself. Founded in 1968, Monell is an independent nonprofit research institute in Philadelphia, Pennsylvania, dedicated to advancing and sharing discoveries in the science of the chemical senses: smell, taste, chemesthesis, and interoception. The institute’s mission explicitly ties basic sensory science to solving the world’s health, societal, and environmental challenges. Lal’s program fits within that tradition of pursuing fundamental biology with an eye toward broad human relevance, even though his model organism might seem, at first glance, far removed from the center’s sensory roots. Interoception, the sense of the body’s internal state, connects directly to the metabolic and neural signals that govern hibernation, appetite, and energy balance.

For early-career scientists, the New Innovator Award represents more than money. It is a signal from the NIH that an investigator’s ideas are considered genuinely original and potentially field-changing, and it often serves as a foundation on which subsequent research careers are built. The program’s explicit tolerance for uncertainty, its willingness to fund projects without preliminary data, reflects a philosophy that the most transformative science often begins as a question that cannot yet be answered with conventional pilot experiments. Lal’s bet on a hibernating rodent as a guide to human chronic disease is exactly the kind of proposition the award exists to test.

The work ahead is substantial. Translating observations from Arctic ground squirrels into treatments for diabetes, muscle wasting, or ischemic injury will require identifying the relevant molecular pathways, validating them in appropriate models, and eventually determining whether they can be safely modulated in humans. The five-year timeline and $3.8 million budget give the Lal laboratory the runway to build the NAMs and genetic toolkits needed to begin that work in earnest, moving from whole-animal observations down to cellular mechanisms and back up again. Whether the squirrels’ secrets can be bottled into therapies remains an open question, but it is precisely the sort of high-stakes, high-curiosity question that the NIH Director’s New Innovator Award was created to champion, and one whose answer could reshape how medicine thinks about chronic disease.

Subject of Research: Hibernation physiology of Arctic ground squirrels as a model for novel treatments of chronic metabolic and neurological diseases

Article Title: Monell investigator receives prestigious NIH director's new Innovator Award

Article References: Monell investigator receives prestigious NIH director's new Innovator Award. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: NIH Director's New Innovator Award, Monell Chemical Senses Center, Arctic ground squirrel, hibernation, insulin resistance, diabetes, muscle wasting, ischemic injury, New Approach Methodologies, early-career investigator, metabolism, chronic disease

The study, led by researchers at Al-Quds University in Jerusalem, set out to measure knowledge, attitudes, readiness, and ethical concerns about precision medicine and pharmacogenomics in diabetes care among medical students across Palestinian universities. Diabetes was chosen as the clinical focus for good reason. Patients with type 2 diabetes can respond very differently to commonly prescribed antidiabetic medications, and genetic differences are increasingly recognized as one driver of that variability. As genomic testing becomes cheaper and more widely available, the question of whether newly trained physicians can actually use this information is becoming urgent in health systems everywhere, not only in the Middle East.

Between June and August 2026, the team conducted a multicenter cross-sectional study using a self-administered online questionnaire. The instrument covered sociodemographic characteristics, educational background, and several carefully structured assessment domains. Knowledge was tested with eighteen true-or-false questions probing the scientific foundations of pharmacogenomics and its application to diabetes treatment. Attitudes, readiness, and ethical concerns were measured with five-point Likert-scale items, a standard survey technique that asks respondents to rate their agreement with statements on a scale ranging from strong disagreement to strong agreement. The researchers then analyzed the responses using descriptive statistics, chi-square tests, Kruskal-Wallis tests, and multivariable logistic regression, a modeling approach that allows investigators to determine which factors independently predict an outcome while controlling for the influence of other variables.

The headline numbers tell a nuanced story. Among the 352 students who participated, 62.2 percent, or 219 individuals, demonstrated adequate knowledge of precision medicine and pharmacogenomics. That is a respectable figure, suggesting that the conceptual building blocks of genomic medicine are reaching students through lectures, textbooks, and self-directed learning. Yet when the researchers turned to attitudes, only 29.3 percent, or 103 students, expressed favorable attitudes toward these technologies. And readiness, the measure of whether students felt prepared to actually use pharmacogenomic information in clinical decision-making, was even lower: just 18.8 percent, or 66 students, met the criterion for readiness. In other words, knowing the science is not the same as being able to practice it.

What separated the well-prepared students from the rest? The regression analysis identified several independent predictors. Greater experience with diabetes pathogenesis and treatment was associated with both adequate knowledge, with an odds ratio of 1.78 and a 95 percent confidence interval of 1.36 to 2.34, and favorable attitudes, with an odds ratio of 1.32 and a confidence interval of 1.06 to 1.65. An odds ratio above 1 means the factor increases the likelihood of the outcome, and because these confidence intervals do not cross 1, the associations are statistically meaningful. Students who had dug deeper into how diabetes develops and how it is treated simply knew more and felt more positive about genomic approaches to care.

Readiness followed a different logic. It was independently associated with greater experience in biostatistics, with an odds ratio of 1.55 and a confidence interval of 1.17 to 2.06, and with previous formal study of genetics, with an odds ratio of 5.17 and a confidence interval of 1.21 to 22.15. That last figure is remarkable: students who had previously studied genetics were more than five times as likely to feel ready to apply pharmacogenomics in practice. The finding makes intuitive sense. Applying genomic medicine requires the confidence to interpret genetic data, weigh probabilities, and translate laboratory results into treatment decisions, and that confidence appears to be built through direct exposure to genetics coursework and quantitative training rather than through general clinical knowledge alone.

The relationships among the three main outcomes were also revealing. Knowledge was significantly associated with both attitudes and readiness, but the strongest link appeared between attitudes and readiness, measured with a Cramér’s V statistic of 0.39 and a p-value below 0.001. Cramér’s V is a measure of association that ranges from 0 to 1, where higher values indicate stronger relationships between categorical variables. A value of 0.39 suggests a moderate-to-strong connection, meaning that students who viewed pharmacogenomics favorably were much more likely to feel ready to use it. This pattern hints at a psychological pathway: positive attitudes may be a necessary bridge between theoretical knowledge and genuine clinical preparedness, which has direct implications for how educators should design curricula.

Perhaps the most consequential findings concern the curriculum itself. Only 23 percent of the surveyed students believed that pharmacogenomics was adequately covered in their medical education. Yet demand for the subject was overwhelming: 89.2 percent of students supported its inclusion in the curriculum, and 90.9 percent wanted additional training. That gap between what is taught and what students want to learn represents both a problem and an opportunity. The problem is a generation of future physicians entering practice without the tools to interpret an expanding stream of genomic information. The opportunity is an unusually receptive audience; few areas of medical education enjoy near-unanimous student demand, and the authors argue that their findings support integrating structured, clinically oriented, and experiential pharmacogenomics education into medical curricula in Palestine.

Ethical concerns, often cited as a barrier to genomic medicine, formed another dimension of the survey. While the study found that students held measurable concerns about issues such as privacy and the implications of genetic testing, the dominant pattern in the data was enthusiasm constrained by lack of preparation. This matters because the successful deployment of pharmacogenomics depends not only on laboratory technology but on clinicians who can explain genetic results to patients, obtain meaningful informed consent, and navigate questions about data security and equitable access. Education that ignores the ethical dimension risks producing physicians who are technically capable but unprepared for the conversations that genomic medicine inevitably triggers in the clinic.

The broader lesson extends well beyond Palestine. Health systems worldwide are grappling with how to move pharmacogenomics from research papers into routine prescribing, and workforce readiness has emerged as a universal bottleneck. This study offers a template for measuring that readiness and a clear diagnosis of where the pipeline breaks: conceptual knowledge is being transmitted, but the applied, statistical, and ethical competencies that turn knowledge into practice are not. The authors received ethical approval from the Al-Quds University Research Ethics Committee, conducted the work without external funding, and published their findings open access so that educators elsewhere can build on them. If the next generation of doctors is to prescribe drugs matched to a patient’s DNA rather than to a population average, medical schools will need to close the gap this study has so precisely measured, and they will need to do it before their students graduate into clinics where genomic data is already waiting in the chart.

Subject of Research: Medical students' knowledge and readiness for pharmacogenomics in diabetes care

Article Title: Knowledge and readiness toward precision medicine and pharmacogenomics in diabetes care among medical students: a cross-sectional study

Article References: Faroun, J., Ayasa, Y., Madaka, S., Alayasa, S., Bael, P., & Ereqat, S. (2026). Knowledge and readiness toward precision medicine and pharmacogenomics in diabetes care among medical students: a cross-sectional study. BMC Medical Education. https://doi.org/10.1186/s12909-026-10548-5

Image Credits: AI Generated

DOI: 10.1186/s12909-026-10548-5

Keywords: pharmacogenomics, precision medicine, diabetes, medical education, medical students, genetics, curriculum, cross-sectional study, clinical readiness, Palestine, biostatistics, personalized medicine

Cerebral small vessel disease sits at the center of the story. It is the chronic, cumulative damage to the brain’s tiniest blood vessels, and it is a leading contributor to stroke and cognitive decline in older adults. On magnetic resonance imaging, the disease announces itself in two complementary ways. The first is the white matter hyperintensity, or WMH: bright patches that appear on certain MRI sequences where tissue has been damaged by chronic ischemia, blood-brain barrier leakage, and gliosis. The second is subtler and requires diffusion-weighted imaging, which tracks the random motion of water molecules through tissue. In healthy white matter, water diffuses preferentially along the direction of nerve fiber bundles, a property quantified as fractional anisotropy, or FA. When the microstructure of those bundles breaks down, FA falls. A companion measure, free water, estimates the fraction of the signal that comes from unconstrained extracellular fluid, and it rises when inflammation, atrophy, or vascular injury opens up space around the fibers.

The research team, led by Elmira Agah, Charles DeCarli, and Pauline Maillard of the University of California, Davis, together with collaborators across multiple field centers, applied these measures to 1,619 cognitively normal participants, most of them older adults, imaged on standardized 3-Tesla MRI protocols. Restricting the sample to people without cognitive impairment was a deliberate choice: it allows the earliest structural signatures of vascular brain injury to be detected before symptoms emerge, when interventions such as blood pressure control might still alter the trajectory. The participants represented the remarkable heterogeneity of the US Hispanic/Latino population, with heritage groups including Mexican, Cuban, Puerto Rican, Dominican, and Central or South American backgrounds.

The statistical approach was straightforward but rigorous. Linear regression models tested whether each vascular risk factor, namely hypertension, diabetes, total cholesterol of 200 mg/dL or higher, and ever-smoking, was associated with the white matter measures, with adjustments for age, sex, education, and field center. The team then asked whether heritage itself predicted white matter outcomes and, critically, whether the effects of vascular risk factors differed across heritage groups. Multiple comparisons were controlled using false discovery rate methods, a standard safeguard against spurious findings when many tracts and measures are tested simultaneously.

The results on vascular risk were unambiguous. Hypertension was associated with higher free water and greater white matter hyperintensity burden, both statistically robust at p < 0.001, and diabetes showed the same pattern, additionally linked to reduced fractional anisotropy. In other words, both conditions were tied to more visible tissue damage and to microscopic disruption of the fiber bundles themselves. Elevated cholesterol and ever-smoking showed weaker or more conditional associations. These results align with a large body of work, including analyses from the UK Biobank and the Atherosclerosis Risk in Communities study, showing that midlife and late-life vascular risk leaves durable marks on the brain’s structural connectivity. They also reinforce the clinical message that blood pressure and glycemic control are, in effect, brain protection strategies.

The heritage findings are what elevate the study beyond a confirmation of known biology. Compared with Mexican participants, Cuban participants showed significantly higher levels of both free water and white matter hyperintensities, and Puerto Rican participants showed higher WMH burden, after full adjustment for vascular risk factors and demographics. Tract-level analyses, which examined individual fiber pathways such as those connecting distant cortical regions, mirrored the overall pattern, with more impaired measures among Cuban and Puerto Rican participants. Because the models adjusted for the measured risk factors, the differences cannot be explained simply by higher rates of hypertension or diabetes in those groups, although the burden of such factors is known from prior HCHS/SOL work to vary considerably across heritage backgrounds.

There was one notable exception to the pattern of uniform risk effects: smoking. The interaction analysis revealed that smoking was associated with higher free water and lower fractional anisotropy among Cuban and Puerto Rican participants, and with lower FA among Central and South American participants, relative to Mexican participants. This suggests that the same exposure may translate into different degrees of brain injury depending on genetic ancestry, environmental context, dietary patterns, acculturation, or other unmeasured variables that cluster within heritage groups. Disentangling those possibilities is now a central question for follow-up research.

The implications reach well beyond epidemiology. Hispanic/Latino adults experience a high burden of vascular risk factors, and prior studies have documented disparities in hypertension awareness, treatment, and control within this population. Because white matter hyperintensities and microstructural damage predict incident stroke, mild cognitive impairment, dementia, and mortality in longitudinal cohorts, the white matter measures used here function as early warning indicators. If heritage-specific vulnerabilities exist, then prevention programs calibrated for one subgroup may not serve another equally well, and clinical trials of vascular risk reduction in diverse Latino populations should be powered and stratified accordingly. The authors also point toward broader social determinants, including the documented pathways linking racism, xenophobia, discrimination, and structural inequity to cardiometabolic outcomes, as candidate explanations that deserve systematic investigation rather than casual attribution to genetics alone.

Technically, the study showcases how far neuroimaging biomarkers have matured. Free water imaging, originally developed to separate extracellular fluid contamination from true tissue diffusion signal, has proven sensitive to early-stage small vessel disease, detecting alterations in tissue surrounding visible hyperintensities before those regions brighten on conventional scans. Atlas-guided tract reconstruction allowed the team to examine specific white matter pathways comprehensively and automatically, and convolutional neural network segmentation tools now make production-level brain parcellation feasible across large cohorts. Combining these tools with a population-based, multi-heritage cohort design is what gives the study its distinctive power.

The authors are careful about what the data cannot say. This was a cross-sectional analysis, so it captures associations at a single point in time rather than the evolution of white matter injury over years. Residual confounding is possible, and the observed heritage differences, while statistically significant, warrant replication and mechanistic follow-up. Yet the central conclusion stands firmly: white matter integrity differs meaningfully across Hispanic/Latino heritage groups even among cognitively normal older adults with comparable measured risk profiles, and treating this population as a monolith obscures real variation in brain aging. As the demographic weight of the US Latino population grows, studies like SOL-INCA make the case that precision in both research and medicine must extend to heritage, not merely to broad ethnic categories.

Subject of Research: Vascular risk factors and white matter integrity in older Hispanic/Latino adults

Article Title: Association between vascular risk factors and white matter integrity among diverse predominantly older Hispanic/Latino adults from the SOL-INCA MRI study

Article References: Agah, E., Testai, F. D., Daviglus, M., Zhou, H., Isasi, C. R., Gallo, L. C., Talavera, G. A., Agudelo, C., Cordero, C., Sotres-Alvarez, D., Tarraf, W., Gonzalez, H., DeCarli, C., & Maillard, P. (2026). Association between vascular risk factors and white matter integrity among diverse predominantly older Hispanic/Latino adults from the SOL-INCA MRI study. GeroScience. https://doi.org/10.1007/s11357-026-02503-5

Image Credits: AI Generated

DOI: 10.1007/s11357-026-02503-5

Keywords: white matter integrity, cerebral small vessel disease, hypertension, diabetes, Hispanic/Latino health, SOL-INCA, MRI, free water imaging, fractional anisotropy, white matter hyperintensities, brain aging, health disparities

The analytical framework behind the study is the syndemic approach, a concept introduced by medical anthropologist Merrill Singer in the late 1990s. Syndemic theory holds that diseases do not merely coexist; they interact synergistically within populations shaped by poverty, inequality, and structural violence, producing a health burden greater than the sum of individual conditions. The framework was originally developed to explain how HIV/AIDS, substance use, and violence reinforced one another in marginalized communities, and it has since been applied to depression and diabetes among populations affected by migration and urban violence in Chicago. What makes the new Mexican study distinctive is its application of this lens to nationally representative data, treating cardiometabolic and cardio-renal disease clusters not as isolated diagnoses but as interconnected systems that amplify mental health risk.

Methodologically, the researchers pooled three independent cross-sectional waves of ENSANUT, combining 13,402 adults from 2021, 11,913 from 2022, and 6,772 from 2023 into a single sample of 32,087 people aged 20 and older. Because each annual wave is an independent, nationally representative sample with no repeated individuals, the pooled dataset increases statistical power without introducing duplicate observations. The survey weights, strata, and clusters built into the complex sampling design were applied throughout, allowing the results to represent roughly 125 million Mexicans living in private dwellings. Response rates were 84 percent in 2021 and 73 percent in 2022, and the 2023 wave followed the same sampling framework, ensuring comparability across years.

Depressive symptoms were measured with the abbreviated version of the Centre for Epidemiologic Studies Depression Scale, a seven-item instrument validated for the Mexican population. The researchers applied a cut-off of nine or more points for adults aged 20 to 59 and five or more points for those aged 60 and above, following previous validation studies. Suicidal ideation was captured through a self-reported item in the adult questionnaire asking whether participants had experienced thoughts of ending their life during a defined recall period. Rather than analyzing these outcomes separately, the team constructed a four-category multinomial outcome: depressive symptoms alone, suicidal ideation alone, both conditions, and neither. This design allowed them to distinguish between people who experience distress in one form and those who carry the heaviest combined burden.

The statistical engine of the study was multinomial logistic regression, which yields relative risk ratios expressing the probability of belonging to each outcome category compared with the reference group of adults reporting neither condition. Two interaction terms were specified in advance on theoretical grounds rather than discovered through exploratory testing. The first was a three-way interaction among diabetes, hypertension, and obesity, representing cardiometabolic multimorbidity. The second was a two-way interaction between chronic kidney disease and cardiovascular disease, representing the cardio-renal axis of advanced target-organ damage. The model showed significant overall fit with a McFadden pseudo R-squared of 0.11, and adding the interaction terms improved the log-likelihood from minus 24,742.1 to minus 24,293.4, a difference that was statistically significant.

The results of these interaction tests are striking. Adults living with all three cardiometabolic conditions had more than double the relative probability of suicidal ideation compared with those without them, and more than four times the probability of experiencing depressive symptoms and suicidal thoughts together. The cardio-renal combination proved even more potent: people with both chronic kidney disease and cardiovascular disease showed a 3.55-fold higher relative probability of suicidal ideation and a 6.78-fold higher probability of the combined outcome. These estimates exceeded those for cardiometabolic multimorbidity, marking the convergence of renal and cardiovascular disease as the single most dangerous clinical configuration in the analysis. The effect remained stable and significant across all model specifications, including those adjusted for sociodemographic and lifestyle variables.

Sociodemographic patterns added a second layer of vulnerability. Women accounted for 65.8 percent of depressive symptom cases and 71.5 percent of cases where depression coexisted with suicidal ideation, and being female more than doubled the relative probability of depressive symptoms. Age produced a striking divergence: adults aged 60 and older made up nearly half of all depressive symptom cases, with a probability more than four times higher than younger adults, yet suicidal ideation was concentrated overwhelmingly among people aged 20 to 59, who accounted for 92.5 percent of such reports. Hypertension was present in 45.4 percent of those with depressive symptoms and 57.8 percent of those with both outcomes, while obesity doubled its prevalence in the coexistence group compared with the general population.

Social and behavioral conditions carved the gradient even deeper. Adults in the highest economic well-being tertile had roughly half the probability of depressive symptoms and less than half the probability of the combined outcome compared with the poorest tertile, a finding consistent with decades of research linking income to mental health. Urban residence increased the likelihood of suicidal ideation by 43 percent and of the combined outcome by 58 percent, a pattern the authors attribute to the concentration of psychosocial stressors such as social fragmentation, economic inequality, and exposure to violence in cities. Non-smokers showed consistently lower probabilities of adverse outcomes, and alcohol abstinence was associated with a significant reduction in the probability of coexisting depression and suicidal thoughts. The authors caution, however, that the cross-sectional design prevents any claim about causality or direction, since it is impossible to determine whether depression precedes hypertension or follows it.

The public health implications are considerable. The authors argue that screening for depressive symptoms and suicidal ideation should be systematically integrated into chronic disease management programs, particularly for patients with cardiometabolic and cardio-renal multimorbidity, and they point to task-shifting strategies involving trained primary care personnel and community health workers as a feasible route to earlier detection. They also emphasize that similar syndemic patterns have been documented in Brazil and Colombia, suggesting that the Mexican findings reflect broader structural dynamics across Latin America and offering opportunities for regional policy learning. The study’s limitations, including self-reported symptoms that may underestimate suicidal ideation due to stigma and the absence of contextual variables such as community violence and discrimination, point toward future longitudinal and multilevel research. Still, the central message stands: mental health care in Mexico cannot remain separate from chronic disease care, because the two are bound together in a web of biological and social amplification that no single-service intervention can untangle.

Subject of Research: Syndemic interactions between chronic diseases, social conditions, and mental health in Mexican adults

Article Title: Depressive symptoms and suicidal ideation among Mexican adults in a syndemic analysis of chronic comorbidities and social conditions

Article References: Hernández-Álvarez, A., Rodríguez-Hernández, J. M., Fernández-Ortiz, Y. N., Urrego-Ricaurte, D. C., & Campuzano-Rincón, J. C. (2026). Depressive symptoms and suicidal ideation among Mexican adults in a syndemic analysis of chronic comorbidities and social conditions. Discover Social Science and Health, 6(1), Article 95. https://doi.org/10.1007/s44155-026-00425-3

Image Credits: AI Generated

DOI: 10.1007/s44155-026-00425-3

Keywords: depression, suicidal ideation, syndemic, multimorbidity, diabetes, hypertension, obesity, chronic kidney disease, cardiovascular disease, social determinants of health, Mexico, ENSANUT

The evidence base behind the Declaration is unusually robust for a workforce study. ESE’s State of Endocrinology surveys drew responses from approximately 2,400 healthcare professionals and researchers across Europe, including more than 250 specialist nurses, and gathered the perspectives of 36 national endocrine societies. This scale matters because workforce planning in medicine has historically relied on fragmented national data, making it difficult to see continental trends or to compare the situation in one country with another. By aggregating responses at this level, the surveys provide the first truly panoramic view of how many endocrine specialists Europe has, what conditions they work under, and whether the pipeline of future expertise is sufficient to meet projected demand. The answer, according to the data, is that it is not.

Among the most striking findings is the length of time patients must wait to see a specialist. More than a quarter of endocrine professionals surveyed reported that new patients at their services wait upwards of 90 days for an appointment. In endocrine medicine, such delays are not merely inconvenient. Conditions such as suspected adrenal insufficiency, thyroid disorders, pituitary tumours and severe metabolic disease can progress substantially during months of waiting, and some, like adrenal crisis in undiagnosed primary adrenal insufficiency, can be life-threatening. Delayed diagnosis also multiplies downstream costs, because advanced disease is more expensive to treat than early disease. Most national societies responding to the surveys expect the gap between demand and capacity to widen further, suggesting that the current waiting-time figures represent a floor rather than a ceiling.

The surveys also document a workforce under significant psychological strain. Stress and burnout are reported as common across the profession, with the burden falling particularly heavily on younger endocrinologists at the start of their careers. More than a third of early-career professionals said they are considering leaving their jobs within the next five years. That figure should alarm policymakers for a straightforward arithmetic reason: early-career specialists represent the future supply of expertise, and if a large fraction of that cohort exits the profession, the workforce cannot replenish itself fast enough to replace both those leavers and the senior clinicians approaching retirement. Burnout in medicine is well documented to correlate with reduced quality of care, higher error rates and increased turnover, creating a feedback loop in which understaffing drives exhaustion, which drives further attrition, which deepens the original understaffing.

Research capacity is suffering alongside clinical capacity. Four in ten respondents reported that they do not have enough time to contribute to research that would improve patient care. This is a problem with long time horizons, because endocrinology research underpins advances in diabetes management, obesity treatment, thyroid cancer therapy, reproductive medicine and rare disease diagnosis. When clinicians cannot participate in research, clinical trials recruit more slowly, translational findings take longer to reach the bedside, and the specialty’s evidence base stagnates. The Declaration frames protected research time and dedicated funding not as a luxury but as a critical investment in future healthcare, arguing that the skills and knowledge generated today determine the treatment options available to patients a decade from now.

Wiebke Arlt, President of the European Society of Endocrinology, framed the crisis in terms of the broader health challenges facing the continent. Europe’s endocrine workforce, she noted, bears the brunt of many of the biggest and most costly health problems of our time, and as obesity, diabetes and other hormone-related diseases affect more people, there must be enough specialist expertise to provide timely, high-quality care. Her point connects endocrinology directly to the economics of chronic disease. Diabetes alone affects tens of millions of Europeans and consumes a substantial share of health budgets, and obesity rates continue to climb in nearly every member state. Every one of those patients ultimately depends on endocrine expertise somewhere in their care pathway, whether for diagnosis, for management of complications or for access to newer pharmacological therapies that have transformed the field in recent years.

Jérôme Bertherat, Chair of the ESE Policy and Advocacy Committee, emphasised that the Declaration is grounded in data rather than anecdote. For the first time, he said, robust survey data show what needs to change, and through the Prague Declaration the society is asking European institutions, national governments, healthcare organisations and medical societies to act on the findings and ensure a resilient and future-proof endocrine workforce. The distinction between advocacy based on impression and advocacy based on systematic survey evidence is important in Brussels, where competing claims on health policy attention are numerous. A documented waiting-time statistic or an attrition figure carries weight in budget negotiations that a general warning about workforce shortages does not.

The 29 recommendations are organised around five key areas. The first calls for more proactive and detailed workforce planning to meet future healthcare needs in both prevalent endocrine and metabolic diseases and complex rare diseases, acknowledging that the specialty spans everything from common diabetes care to ultra-rare adrenal and pituitary conditions. The second addresses the demand-capacity gap directly, promoting prevention, early detection, shared care protocols and new working methods, including artificial intelligence, remote disease monitoring and future technologies, to alleviate the burden of providing increasingly costly and specialised care. The third focuses on working conditions, wellbeing and career support, urging workplace policies that enable flexible careers and ensure early-career professionals feel sufficiently supported. The fourth protects time and funding for research, and the fifth supports fair and sustainable workforce mobility through standardised education and training across European countries and beyond, recognising that free movement of specialists only benefits all parties if qualifications are comparable across borders.

The emphasis on prevention deserves particular attention because it reframes the workforce crisis as a system-wide problem rather than a specialty-specific one. The Declaration notes that better endocrine care can reduce pressures in other specialties, including oncology and cardiology, since endocrine disorders intersect with cancer risk, cardiovascular disease and metabolic dysfunction in ways that are increasingly well understood. Hormonal health, in other words, is not an isolated domain but a foundation on which much of modern medicine rests. An adequately staffed endocrine service that catches thyroid disease early, manages diabetes intensively and identifies metabolic syndrome before it progresses prevents hospitalisations, procedures and drug costs elsewhere in the system. Supporting the endocrine workforce, the Declaration argues, is therefore a strategic investment in Europe’s future health rather than a narrow plea from one professional community.

Whether the Declaration translates into policy will depend on the response of the institutions it addresses. The document provides European and national decision-makers with a clear menu of actions, from workforce planning frameworks to training standardisation to technology adoption, each anchored in survey evidence. What the data make unmistakable is that the status quo is deteriorating: waiting times already exceed 90 days for many new patients, a substantial share of the next generation of specialists is contemplating departure, and four in ten clinicians lack time for research. Hormones regulate growth, metabolism, reproduction and stress, and the physicians and scientists who manage those systems are telling Europe, in the largest survey of its kind, that their capacity to keep doing so is eroding. The Prague Declaration is the profession’s formal request that someone in a position to act start listening before the gap between what patients need and what the workforce can deliver becomes unbridgeable.

Subject of Research: Endocrine workforce shortages and policy recommendations in Europe

Article Title: Europe’s endocrine community calls for urgent policy action as growing demand puts hormone health workforce under pressure

Article References: Europe’s endocrine community calls for urgent policy action as growing demand puts hormone health workforce under pressure. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: endocrinology, workforce shortage, Prague Declaration, European Society of Endocrinology, burnout, diabetes, obesity, health policy, patient waiting times, medical research, workforce planning, hormone health

The study was led by Majed M. Aljabri, Alya Alghamdi, and Bandar S. Alharbi, researchers in the Community and Psychiatric Mental Health Nursing Department at the College of Nursing, King Saud University in Riyadh. The team recruited 413 adults with diabetes who were attending primary healthcare centers in the Saudi capital. Roughly one-third of the participants — 31.0 percent — had lived with diabetes for more than a decade, and just over a quarter, 26.9 percent, reported experiencing diabetes-related complications, a reminder that the cohort included many people for whom the stakes of good self-care were already painfully concrete. Ethical approval was obtained from the Research Ethics Committee of King Saud University, and the study was conducted in accordance with the principles of the Declaration of Helsinki, with informed consent from all participants.

To capture the psychological dimensions of the problem, the researchers deployed three well-established instruments. The 18-item Multidimensional Health Locus of Control Scale, or MHLC, breaks health-related beliefs into distinct components: Internal Health Locus of Control, reflecting confidence in one’s own agency; Powerful Others Health Locus of Control, reflecting reliance on healthcare professionals and other authority figures; and Chance or Fate Health Locus of Control, reflecting the sense that health outcomes are determined by luck or destiny. Illness perceptions were measured with the Brief Illness Perception Questionnaire, which probes how patients understand their condition — its consequences, its timeline, its controllability, and the emotional weight it carries. Self-care behavior was assessed with the Summary of Diabetes Self-Care Activities, a validated measure covering domains such as diet, exercise, blood glucose testing, foot care, and medication adherence.

The analytical strategy unfolded in two stages, each answering a different question. First, the team used multivariable linear regression to ask whether each locus-of-control dimension was associated with diabetes self-care after statistically adjusting for sociodemographic and clinical characteristics — a crucial step, because raw correlations between beliefs and behavior can easily be distorted by age, education, disease duration, or the presence of complications. Second, the researchers turned to structural equation modeling, a statistical framework that allows investigators to test hypothesized pathways linking variables simultaneously, including indirect effects that pass through an intermediate variable. Here, the intermediate variable was positive illness perception, and the question was whether locus of control influences self-care directly, or whether it works by first shaping how patients mentally frame their disease.

The regression results were striking in their asymmetry. Internal Health Locus of Control showed a positive association with diabetes self-care, with a standardized coefficient of 0.29 and a 95 percent confidence interval running from 0.11 to 0.47. Powerful Others Health Locus of Control was nearly identical in magnitude, with a coefficient of 0.28 and a confidence interval of 0.09 to 0.47. In plain terms, people who believed they controlled their own health, and people who trusted the power of their healthcare providers, both tended to report better self-care. The Chance and Fate dimension, by contrast, showed no significant direct association with self-care at all — a finding that might seem to suggest fatalism is irrelevant to diabetes management, until the structural equation modeling revealed otherwise.

That second stage of analysis is where the study becomes genuinely illuminating. Internal Health Locus of Control was strongly and positively associated with positive illness perceptions, with a coefficient of 0.620 and a p-value below 0.001. Positive illness perceptions, in turn, were strongly associated with better diabetes self-care, with a coefficient of 0.506, again at p below 0.001. When the researchers traced the indirect pathway — from internal control beliefs, through more constructive perceptions of the illness, to self-care behavior — the indirect effect was 0.314, with a confidence interval of 0.126 to 0.502 that excluded zero. In other words, a substantial share of the relationship between believing in one’s own agency and actually practicing good self-care appears to run through the way patients conceptualize their disease: how controllable they judge it to be, how serious they consider its consequences, and how coherent their understanding of it feels.

Perhaps the most unexpected result concerned the Chance and Fate dimension. Although fatalistic beliefs showed no direct link to self-care in the regression models, the structural equation model detected a significant indirect association: the pathway from Chance Health Locus of Control through positive illness perceptions to self-care carried a coefficient of 0.113, with a confidence interval of 0.025 to 0.201. This suggests that the relationship between fatalism and diabetes behavior is more nuanced than a simple negative correlation. The authors concluded that Internal and Chance dimensions of health locus of control are associated with self-care primarily through their relationships with illness perceptions, whereas the Powerful Others dimension showed a direct association with self-care behavior — implying that trust in clinicians may motivate action more immediately, without needing to first reshape how the patient views the disease.

The clinical implications of this pathway analysis are considerable. Diabetes self-care is the foundation of glycemic control and the primary defense against the long-term complications that make diabetes one of the world’s most burdensome chronic diseases — retinopathy, nephropathy, neuropathy, and cardiovascular disease among them. Yet self-care is notoriously difficult to change through education alone. If the Saudi findings generalize, interventions that target illness perceptions — for example, helping patients develop a more coherent and controllable mental model of their diabetes — could unlock self-care improvements that information-only programs fail to achieve. The results also hint that different patients may need different psychological levers: those with strong internal control beliefs might benefit most from perception-focused work, while those who defer heavily to their doctors may respond well to structured clinical support and clear, actionable guidance from trusted providers.

The study’s context matters as well. Saudi Arabia faces a substantial and growing diabetes burden, and primary healthcare centers in Riyadh serve a diverse population in which cultural and religious framings of health and destiny can shape how illness is understood. The cross-sectional design, however, imposes an important limitation: because beliefs, perceptions, and behaviors were all measured at a single point in time, the analysis cannot prove that locus of control causes illness perceptions, or that illness perceptions cause self-care. Reverse pathways — in which successful self-management fosters a stronger sense of control, for instance — remain plausible, and longitudinal or interventional studies will be needed to establish directionality. The authors also relied on self-report instruments, which are vulnerable to social desirability and recall bias, although all three scales are widely validated in diabetes research.

Even with those caveats, the research adds a compelling piece to the psychology of chronic disease management. It suggests that the mind’s model of an illness is not merely a passive reflection of medical facts but an active mechanism that converts belief into behavior. For the 413 adults in Riyadh who participated, and for the hundreds of millions of people worldwide living with diabetes, the message is that how you think about your disease — whether you see it as manageable, coherent, and within your influence — may matter almost as much as the medications in your cabinet. And for the clinicians treating them, the study argues that listening to how patients perceive their illness could be as clinically productive as prescribing the next dose.

Subject of Research: Health locus of control, illness perceptions, and diabetes self-care among adults with diabetes in Saudi Arabia

Article Title: Associations of health locus of control with diabetes self-care: the role of illness perceptions among adults with diabetes in Saudi Arabia

Article References: Aljabri, M. M., Alghamdi, A., & Alharbi, B. S. (2026). Associations of health locus of control with diabetes self-care: the role of illness perceptions among adults with diabetes in Saudi Arabia. BMC Endocrine Disorders. https://doi.org/10.1186/s12902-026-02567-6

Image Credits: AI Generated

DOI: 10.1186/s12902-026-02567-6

Keywords: diabetes, health locus of control, illness perceptions, diabetes self-care, self-management, health psychology, structural equation modeling, Saudi Arabia, primary health care, chronic disease, patient behavior, endocrinology

The system in question is autophagy, the cellular recycling program that engulfs damaged proteins and organelles in double-membraned vesicles and delivers them to lysosomes for degradation. Within mitochondria, a specialized form of this process, known as mitophagy, selectively removes dysfunctional mitochondria before they leak reactive oxygen species and trigger cell death. When autophagic flux runs smoothly, the endothelium stays clean and energetic. When it stalls, debris accumulates, mitochondria fragment into dysfunctional shards, and the cell’s metabolic machinery begins to misfire. The French-led research team, working across institutions in Paris and Angers with collaborators in Japan, set out to determine whether calpains, enzymes best known for degrading structural proteins under stress, might be the hidden hand jamming this recycling machinery in diabetes.

The investigators began with human umbilical vein endothelial cells and primary lung endothelial cells exposed to high glucose concentrations in the laboratory. Under these diabetic-mimicking conditions, they observed a clear activation of calpains, detectable through the characteristic cleavage of their substrates. More importantly, they documented a full-blown autophagic flux blockade. The cargo receptor protein SQSTM1, also known as p62, accumulated to abnormal levels because it was no longer being efficiently cleared, while expression of LC3B, the lipidated protein that decorates autophagosomal membranes, was reduced. In practical terms, the conveyor belt carrying cellular waste to the lysosome had ground to a halt, and the mitochondria within these cells responded by fragmenting, losing the elongated, interconnected network architecture that healthy endothelial cells depend upon for efficient energy production.

To test whether calpains were truly the drivers of this collapse rather than innocent bystanders, the team deployed two complementary strategies. The first was pharmacological: small-molecule inhibitors that block calpain enzymatic activity. The second was genetic: overexpression of calpastatin, the endogenous protein that naturally inhibits calpains and serves as the body’s built-in brake on these proteases. Remarkably, both approaches produced the same result. Blocking calpain activity restored autophagic flux, allowing SQSTM1 to be cleared and LC3B-mediated autophagosome formation to resume, and it preserved the mitochondrial network, preventing the pathological fragmentation that hyperglycemia would otherwise induce. The convergence of drug-based and gene-based evidence strengthens the causal argument considerably, ruling out the possibility that the inhibitor was working through some unrelated off-target pathway.

To understand the broader consequences of calpain inhibition at the level of gene expression, the researchers performed transcriptomic profiling of endothelial cells subjected to high glucose with and without calpain blockade. The results revealed that calpain inhibition counteracted several major hyperglycemia-driven transcriptional programs. Among the most prominent were pathways governing oxidative phosphorylation, the mitochondrial process that generates most of the cell’s ATP; reactive oxygen species signaling, which spirals dangerously upward when mitochondria fail; and the unfolded protein response, a stress program activated when the endoplasmic reticulum is overwhelmed. In other words, restraining calpains did not merely patch one leak in the diabetic endothelium but appeared to rebalance an entire constellation of stress responses that high glucose had pushed out of alignment.

The mechanistic picture that emerges is elegant in its simplicity. Hyperglycemia floods endothelial cells with calcium signals and oxidative stress, which overactivate calpains. These proteases then disrupt the autophagy-mitophagy axis, either by directly degrading components of the autophagic machinery or by damaging the lysosomal system that completes the degradation process. With mitophagy impaired, damaged mitochondria escape removal, fragment, and pour out reactive oxygen species, which in turn inflict further damage on proteins and organelles, creating a self-reinforcing cycle of dysfunction. Calpain inhibition breaks this vicious cycle at its upstream point, restoring the cell’s capacity for self-renewal before the downstream damage becomes irreversible. This positions calpains not as one among many secondary casualties of diabetes but as a genuine regulatory node in the pathogenesis of vascular disease.

Crucially, the team did not confine their work to cell culture dishes. They extended their findings into living animals, using mouse models of diabetes to ask whether calpain inhibition could preserve vascular function in the intact organism. The answer was affirmative: treatment that restrained calpain activity preserved vascular reactivity in diabetic mice, the ability of blood vessels to dilate and constrict appropriately in response to physiological cues. This functional rescue is the metric that matters most for translational relevance, because endothelial dysfunction in patients is measured precisely by the loss of this dynamic responsiveness, whether in the coronary arteries feeding the heart or the glomerular capillaries sustaining the kidneys. The study also made use of mitoQC reporter mice, a sophisticated genetic tool developed in Ian Ganley’s laboratory at the University of Dundee, which allows mitophagy to be visualized directly in tissues, providing in vivo confirmation of the cellular findings.

The implications for diabetic patients are significant but must be weighed with appropriate caution. Calpains have been implicated in a wide range of physiological processes, including platelet activation, muscle remodeling, and neuronal function, which means that systemic calpain inhibition carries potential risks that will need careful evaluation. The study’s use of both pharmacological inhibitors and calpastatin overexpression suggests that even partial or tissue-targeted modulation of calpain activity might be sufficient to confer vascular protection, which could open the door to therapeutic strategies that maximize benefit while limiting collateral effects. It is also worth noting that the work was supported by the Société francophone du diabète, Laboratoire Servier, and the EFSD/Novo Nordisk Programme for Diabetes Research in Europe, reflecting a serious institutional commitment to translating basic endothelial biology into clinical applications.

What makes this research resonate beyond the diabetes field is its contribution to a growing appreciation of autophagy as a master regulator of vascular health. Endothelial cells are among the longest-lived cells in the body, exposed continuously to mechanical forces, metabolic fluctuations, and inflammatory insults over decades. Their survival depends on relentless intracellular housekeeping, and any mechanism that compromises that housekeeping, whether it is a protease gone rogue or a lysosome gone sluggish, accelerates vascular aging. By identifying calpain overactivation as a specific and druggable point of failure in the diabetic endothelium, Salemkour, Lenoir, and their colleagues have added a precise new entry to the molecular map of diabetic vascular disease, and they have demonstrated that the map can be redrawn toward health with the right molecular intervention.

The road from a mouse study to a bedside therapy is long, and the authors themselves frame calpain inhibition as a promising strategy rather than a finished treatment. Nevertheless, the convergence of cellular mechanistics, transcriptomic breadth, and intact-animal functional data makes this one of the more complete preclinical demonstrations in the endothelial autophagy literature. For the hundreds of millions of people worldwide living with diabetes, whose risk of cardiovascular death is roughly doubled compared with the general population, the finding that a single enzymatic family stands between high glucose and the collapse of mitochondrial quality control offers something genuinely new: a target that, if safely inhibited, could preserve the vessels that diabetes slowly destroys. The next chapter will be written in the clinic, but the molecular groundwork has now been firmly laid.

Subject of Research: The role of calpain-mediated autophagy and mitophagy blockade in diabetic endothelial dysfunction

Article Title: Calpain inhibition prevents high-glucose-induced autophagy blockade and mitochondrial fragmentation in endothelial cells and preserves vascular functions in diabetic mice

Article References: Salemkour, Y., Dionet, L., Vessieres, E., Saito, R., Le Gall, M., Letavernier, E., Henrion, D., Tharaux, P.-L., & Lenoir, O. (2026). Calpain inhibition prevents high-glucose-induced autophagy blockade and mitochondrial fragmentation in endothelial cells and preserves vascular functions in diabetic mice. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-026-06433-5

Image Credits: AI Generated

DOI: 10.1007/s00018-026-06433-5

Keywords: diabetes, endothelial dysfunction, calpain, autophagy, mitophagy, mitochondria, hyperglycemia, vascular function, calpastatin, oxidative stress, endothelium, diabetic complications

The scale of the potential opportunity is hard to overstate. Dementia affects tens of millions of people worldwide, and the World Health Organization has declared 2021 to 2030 the Decade of Healthy Ageing as populations gray at an unprecedented pace. Yet a substantial share of dementia risk appears to be modifiable. The Lancet Commission on dementia prevention has estimated that addressing risk factors such as hypertension, diabetes, obesity, physical inactivity, smoking, depression, and low social engagement could prevent or delay a meaningful proportion of cases. Epidemiological modeling by Barnes and Yaffe, cited in the review, similarly projected that reductions in risk factor prevalence could substantially lower Alzheimer’s disease prevalence. In other words, the biological pathways that lead to cognitive decline run, in part, through conditions that community-level interventions can reach.

This is precisely where community health workers enter the picture. Also known as promotoras, lay health educators, or community health agents, these workers are typically drawn from the communities they serve, sharing language, culture, and lived experience with the people they visit. The American Public Health Association defines them by this frontline, trusted-member role, and the International Labour Organization classifies them as a distinct occupational category. Their model is perhaps most institutionalized in Brazil, where community health agents form the backbone of the national primary care system under the Unified Health System, making regular home visits to families in their territories. The Brazilian policy framework, revised in 2017 under the National Primary Care Policy, formally embeds these workers in preventive care.

To map what these workers have actually been doing in relation to dementia risk, the research team searched five major databases—Medline, SciELO, PsycINFO, Web of Science, and Scopus—for studies published between January 2000 and October 2021. They applied the PRISMA 2020 reporting guidelines for systematic reviews and included only studies that evaluated community health worker training or interventions aimed at people aged 60 or older. The initial search retrieved 4,370 articles, which the team screened using the Rayyan web application, with study selection and data extraction performed independently and inter-rater agreement assessed using the standard Landis and Koch thresholds. After the full screening process, 35 studies met the inclusion criteria.

The dominant finding was unmistakable: the overwhelming majority of interventions targeted cardiovascular and metabolic risk factors, chiefly hypertension, diabetes, and obesity. These are not arbitrary choices. Midlife hypertension is one of the most robust modifiable predictors of later dementia, and type 2 diabetes and obesity are both independently associated with elevated cognitive decline risk through vascular and metabolic mechanisms. The reviewed studies spanned an impressive geographic and cultural range. In rural India, a cluster randomized controlled trial led by Gamage and colleagues tested a scalable group-based education and monitoring program delivered by health workers to improve blood pressure control. In Nepal, the COBIN trial evaluated female community health volunteers leading a lifestyle intervention for blood pressure reduction. In rural Mexico, a stepped-wedge analysis examined a community health worker program for diabetes and hypertension. In Argentina, a hypertension control program delivered with community workers was subjected to trial-based cost-effectiveness analysis.

Diabetes prevention and management featured especially prominently, particularly in programs serving Latino, African American, Asian American, and Native Hawaiian and Pacific Islander communities in the United States. Studies such as the DIALBEST trial, which showed improvements in blood glucose control among Latinos with type 2 diabetes, the HELP PD trial translating the Diabetes Prevention Program into community settings with lay educators, and randomized trials among Korean, Vietnamese, and Hispanic populations demonstrated that lay workers can achieve measurable improvements in hemoglobin A1c, weight, physical activity, and dietary behaviors. Other studies examined weight-loss interventions translated into senior centers by lay health educators, falls prevention exercise programs delivered by community care workers, physical activity promotion during home visits by Brazilian community agents, and even smoking cessation support, another recognized dementia risk factor.

Yet when the researchers looked specifically for interventions aimed at cognitive stimulation or cognitive training—the direct exercise of memory, attention, and executive functions—they found almost nothing. Only one of the 35 included studies specifically addressed cognitive stimulation. This is a remarkable gap given that meta-analyses of memory training and cognitive training in older adults, including work by Gross and colleagues and by Kelly and colleagues, suggest that structured cognitive practice can improve trained cognitive domains, and that frequent cognitive activity may compensate for educational disadvantages in episodic memory. The review’s authors argue that this absence reveals a field anchored almost entirely in a biomedical model of chronic disease management, in which community health workers are deployed as extensions of clinical care for hypertension and diabetes rather than as promoters of brain health in its own right.

The biomedical anchoring has a second, subtler cost: the neglect of sociocultural context. Although community health workers are prized precisely for their cultural proximity and territorial bonds, the review found that few studies incorporated the sociocultural realities of the communities they served into intervention design. The authors suggest that public policies and training programs that genuinely value these territorial relationships and invest in educational practices could expand what community health workers are able to do. Instead of simply checking blood pressure readings and reinforcing medication adherence, workers could be equipped to engage older adults in conversations about cognitive engagement, social participation, and lifestyle patterns that shape long-term brain health—dimensions that the Lancet Commission identifies as part of the dementia prevention portfolio.

The implications for health equity are significant. Dementia risk is not evenly distributed: low-income populations carry a disproportionate burden of untreated hypertension, uncontrolled diabetes, and limited access to preventive care, and they are also less likely to reach specialized memory clinics. Community health workers operate exactly where these risks concentrate. The evidence reviewed suggests they can contribute to dementia prevention, particularly in low-income settings, by addressing the modifiable conditions—vascular and metabolic—that feed into cognitive decline. If the vascular and metabolic health of midlife and older adulthood shapes dementia risk decades later, then a workforce capable of delivering affordable, culturally attuned chronic disease support at scale is, functionally, a dementia prevention workforce, whether or not it describes itself that way.

The review’s authors are careful about the limits of the evidence. The included studies varied widely in design, outcomes, and quality, and the field lacks trials that follow community health worker–led programs all the way to cognitive outcomes, let alone dementia incidence. The authors call for future research to prioritize cognitive-focused interventions and to specify the training components that make community health workers effective, so that their capacity can be optimized rather than assumed. As global aging accelerates and dementia cases climb, the review’s message is both encouraging and cautionary: the community workforce needed for prevention largely already exists and has proven it can move the metabolic and cardiovascular needles—but almost no one has yet asked it to protect the brain directly. Closing that gap, the authors argue, will require deliberate policy choices, better training, and a research agenda that treats cognitive health not as a specialty concern but as a community one.

Subject of Research: Community health worker–led interventions targeting modifiable dementia risk factors in older adults

Article Title: Community Health Worker–Led Interventions Targeting Modifiable Risk Factors for Dementia in Older Adults: A Systematic Review

Article References: de Souza Pereira, B. L., dos Santos, L. A., Barroso, S. M., & Mansur-Alves, M. (2025). Community Health Worker–Led Interventions Targeting Modifiable Risk Factors for Dementia in Older Adults: A Systematic Review. Trends in Psychology. https://doi.org/10.1007/s43076-025-00493-5

Image Credits: AI Generated

DOI: 10.1007/s43076-025-00493-5

Keywords: community health workers, dementia prevention, modifiable risk factors, older adults, hypertension, diabetes, obesity, cognitive stimulation, systematic review, primary health care, health equity, cognitive aging